2019
DOI: 10.1016/j.taap.2018.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(18 citation statements)
references
References 104 publications
0
18
0
Order By: Relevance
“…For example, both vitamin D and IL-33 promote the differentiation of Th2 lymphocytes by inhibiting Th1 differentiation and also act as inducers of immunoregulatory cells. Vitamin D can downregulate the production of inflammatory cytokines and chemokines (121). Moreover, vitamin D activity is determined through vitamin D receptors, which are present not only in the skeleton but also in different types of cells, including antigenpresenting-cells, immune cells, and keratinocytes.…”
Section: Vitamin D and Il-33 Immunological Crosstalkmentioning
confidence: 99%
See 2 more Smart Citations
“…For example, both vitamin D and IL-33 promote the differentiation of Th2 lymphocytes by inhibiting Th1 differentiation and also act as inducers of immunoregulatory cells. Vitamin D can downregulate the production of inflammatory cytokines and chemokines (121). Moreover, vitamin D activity is determined through vitamin D receptors, which are present not only in the skeleton but also in different types of cells, including antigenpresenting-cells, immune cells, and keratinocytes.…”
Section: Vitamin D and Il-33 Immunological Crosstalkmentioning
confidence: 99%
“…IL-33 may act as an alarmin, exerting both repairing and damaging processes and functioning as a nuclear transcription factor. Similarly, the vitamin D receptor, functioning as a ligand-activated transcription factor, regulates the activation or repression of gene transcription (121). Moreover, vitamin D deficiency likely independently contributes to the increased incidence of OP in Pso patients.…”
Section: Vitamin D and Il-33 Immunological Crosstalkmentioning
confidence: 99%
See 1 more Smart Citation
“…To mention some recent findings concerning CRC, it was shown that alterations in alternative splicing are involved in tumour cell proliferation [ 11 , 12 , 13 , 14 , 15 , 16 ] and invasiveness [ 15 , 17 , 18 , 19 , 20 , 21 , 22 ]. Consequently, the analysis of splice variants has been proposed as a tool for the diagnosis or prognosis of CRC [ 14 , 23 , 24 , 25 , 26 ] and the possibility of targeting specific variants or splicing modulators for therapeutic purposes has also been postulated [ 22 , 26 , 27 , 28 , 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…SSO technology has primarily been exploited as a therapeutic approach to rare genetic diseases such as Duchenne muscular dystrophy (Fall et al, 2006;McClorey et al, 2006a,b;Adams et al, 2007;Fletcher et al, 2007;Koo and Wood, 2013) as highlighted by the Food and Drug Administration approval of Eteplirsen in 2016 (Syed, 2016). The therapeutic utility of SSOs to modulate the immune response have also been explored (Mourich and Iversen, 2009;Mourich et al, 2014;Panchal et al, 2014), as has ligand-independent signaling in the vitamin D receptor (Annalora et al, 2019). The implications of splice-switching small molecules and SSOs as gene-directed therapeutics targeting the pre-mRNA of NR genes underlie the examination of NR splice variants presented here.…”
Section: Introductionmentioning
confidence: 99%